1. Millennium Pharmaceuticals Limited (10 from 850 patents)

2. Sunesis Pharmaceuticals, Inc. (10 from 63 patents)

3. Biogen Ma Inc. (4 from 250 patents)

4. Biogen Idec Ma Inc. (2 from 216 patents)

5. Bioverativ Therapeutics Inc. (1 from 71 patents)

1. 10577374 - Bruton's tyrosine kinase inhibitors

2. 10317376 - Methods of detecting glycosaminoglycans

3. 9920048 - Substituted pyrimidines for inhibiting Raf kinase activity

4. 9790229 - Bruton's tyrosine kinase inhibitors

5. 9273028 - Heterocyclic tyrosine kinase inhibitors

6. 9249146 - Bruton'S tyrosine kinase inhibitors

7. 9029359 - Heteroaryl Btk inhibitors

8. 8802657 - Compounds useful as Raf kinase inhibitors

9. 8785440 - Bruton's tyrosine kinase inhibitors

10. 8293752 - Compounds useful as Raf kinase inhibitors

11. 8063222 - Aryl sulfonamides useful as inhibitors of chemokine receptor activity

12. 7968536 - Heterocyclic compounds useful as RAF kinase inhibitors

13. 7491827 - Aryl sulfonamides useful as inhibitors of chemokine receptor activity

14. 7378525 - CCR8 inhibitors

15. 7329755 - CCR8 inhibitors